glutamine has been researched along with abt-199 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birsen, R; Bouscary, D; Chapuis, N; Decroocq, J; Demo, S; Hospital, MA; Jacque, N; Joseph, L; Lacombe, C; Lambert, M; Larrue, C; Maciel, TT; Mayeux, P; Meunier, G; Moura, IC; Poulain, L; Recher, C; Ronchetti, AM; Saland, E; Sarry, JE; Sujobert, P; Tamburini, J; Willems, L | 1 |
| Bajpai, R; Boise, LH; Lonial, S; Matulis, SM; Nooka, AK; Shanmugam, M; Von Hollen, HE; Wei, C | 1 |
| Al-Zebeeby, A; Alotibi, A; Cohen, GM; Dyer, MJS; Greaves, G; Milani, M; Richards, C; Varadarajan, S; Vogler, M | 1 |
| Cai, Q; Che, Y; Chen, Z; Jiang, VC; Jordan, A; Leeming, A; Li, L; Li, Y; Liu, Y; Nie, L; Vargas, J; Wang, M; Wang, W; Yao, Y | 1 |
4 other study(ies) available for glutamine and abt-199
| Article | Year |
|---|---|
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzeneacetamides; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Citric Acid Cycle; Enzyme Inhibitors; Gene Knockdown Techniques; Glutaminase; Glutamine; Humans; Leukemia, Myeloid, Acute; Mice; Mitochondria; Oxidative Phosphorylation; Oxygen Consumption; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiadiazoles; Xenograft Model Antitumor Assays | 2015 |
Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax.
Topics: Antineoplastic Agents; Bcl-2-Like Protein 11; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Glucose Transporter Type 4; Glutamine; Humans; Multiple Myeloma; Proto-Oncogene Proteins c-bcl-2; Ritonavir; Sulfonamides | 2016 |
Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies.
Topics: Antineoplastic Agents; bcl-X Protein; Benzothiazoles; Biomimetics; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Glutamine; Humans; Indoles; Isoquinolines; Leukemia, Lymphocytic, Chronic, B-Cell; Lipogenesis; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Recurrence, Local; Peptide Fragments; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2019 |
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma.
Topics: Adult; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutaminase; Glutamine; Humans; Lymphoma, Mantle-Cell; Neoplasm Recurrence, Local | 2023 |